Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort

Marinda Meertens, Eline L. Giraud, the Dutch Pharmacology Oncology Group (DPOG), Maud B.A. van der Kleij, Kim Westerdijk, Niels A.D. Guchelaar, Roos F. Bleckman, Amy Rieborn, Alex L.T. Imholz, Hans Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T.A. van der Graaf, Hans Gelderblom, Dirk Jan A.R. Moes, K. Esther Broekman, Daan J. Touw, Stijn L.W. Koolen, Ron H.J. MathijssenAlwin D.R. Huitema, Nielka P. van Erp, Ingrid M.E. Desar, Neeltje Steeghs*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science